RheumatologyNetwork Presents RA Findings from ACR Annual Meeting
NORWALK, Conn., Dec. 3, 2013 /PRNewswire/ — UBM Medica US announces two new videos on RheumatologyNetwork, the leading online community for rheumatologists, describing startling findings about rheumatoid arthritis, an autoimmune condition that affects about 1.3 million adults in the United States.
Despite dramatic advances in new drugs for rheumatoid arthritis (RA) treatment, according to research presented at the recent American College of Rheumatology annual meeting in San Diego (and recounted in the videos):
-- Many patients continue to experience considerable pain months after treatment with the new biologic drugs has started, even though their doctors may think that treatment has been successful because inflammation has been reduced -- Urged by national guidelines to begin treatment for rheumatoid arthritis as soon as possible because the new medications are so successful, some doctors run the risk of initiating treatment for patients who would recover spontaneously.
Research from the Karolinska University Hospital in Sweden, described in the video “Big Flaw in RA Treatment Success Record: Remaining Pain” by Karolinska rheumatologist Jon Lampa, tracked records from more than 8000 RA patients and controls in a Swedish database and found that many continued to have pain three months after beginning treatment. It’s important for doctors to track pain as well as inflammation, he says.
Many rheumatologists refer to a “window of opportunity” during which they can begin to treat RA early enough so that it never becomes severe. In the video “When Does the RA Window of Opportunity Actually Open” by rheumatologist Ellen Sauar Norli MD of the Martina Hanssens Hospital in Gjettem, Norway, the authors try to define the duration of pain and clinical indicators that optimize the likelihood that joint pain actually represents rheumatoid arthritis and not a more transient problem, before rheumatologists initiate treatment with expensive and potentially dangerous drugs.
About UBM Medica US
Addressing today’s healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach — online, in print, via custom programs and live events. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers and payers resulting in improved quality of care for patients around the world.. Through journals, magazines, online communities, live and digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Online communities include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect which, through a range of aligned interactive environments, both physical and digital – increases business effectiveness for both customers and audiences through meaningful experiences, knowledge and connections. Headquartered in New York, UBM Connect brings together UBM’s healthcare business, UBM Medica US; UBM Canon’s advanced design and manufacturing event, online and print brands; UBM Connect New York’s catering, cruise shipping, customer management, and fine, specialty and custom chemical communities; and UBM Mexico’s concrete show. For more information, visit www.UBMMedicaUS.com.
About UBM plc
UBM plc is a global events-led marketing services and communications company. We help businesses do business, bringing the world’s buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organized into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.
For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.
Jason J. Golden
Content Marketing Manager
SOURCE UBM Medica US